My Cart [ 0 ]
Home > Antibodies > Research-Grade Biosimilars > Belatacept Biosimilar

Belatacept Biosimilar

Nulojix, CTLA-4 Fc Fusion Protein

Catalog No. Product Name Size List Price (US$) Quantity
C008P Belatacept Biosimilar 1 mg 400.00
C008P Belatacept Biosimilar 5 mg 800.00
C008P Belatacept Biosimilar 20 mg 1600.00
Description

Belatacept (trade name Nulojix, Bristol-Myers-Squibb), a fusion protein of a Fc fragment (human IgG1 isotype) and the extracellular domain of CTLA-4, can be used to extend graft survival while limiting the toxicity generated by standard immune suppressing regimens, such as calcineurin inhibitors. Belatacept differs from abatacept (trade name Orencia) by only 2 amino acids.

The CTLA-4 protein is important for T-cell costimulation and selectively blocks the process of T-cell activation.

C008P: Belatacept Biosimilar

Recombinant protein composed of the extracellular domain of CTLA-4 fused with the Fc region of human immunoglobulin gamma 1 (hIgG1).
Source: The belatacept biosimilar protein was produced in the Nulojix biosimilar CHO stable cell line.
Specificity/Sensitivity: The belatacept biosimilar protein specifically binds to the human CD80 (B7-1) with more avidity than to CD86 (B7-2).
Applications: Functional assays, and those assays for studying biological pathways affected by belatacept.
Form of Protein: 0.2 uM filtered solution, pH 7.2 to 7.8, no stabilizers or preservatives.
Endotoxin: <1 EU/mg of the protein by the LAL method.
Purity: >95% by SDS-PAGE under reducing conditions and HPLC.

Shipping: The belatacept biosimilar protein is shipped with ice pack. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
12 months from date of receipt, -20 to -70°C as supplied.
1 month from date of receipt, 2 to 8°C as supplied.

Syd Labs also provides the following CTLA-4 Fc Fusion Protein biosimilar:
Abatacept Biosimilar

Syd Labs provides the following research grade anti-CTLA-4 antibody biosimilars:
Ipilimumab Biosimilar, research grade, anti-human CTLA-4 monoclonal antibody
Tremelimumab Biosimilar, research grade, anti-human CTLA-4 monoclonal antibody

Related Links

See our Privacy Policy